Is screening effective in detecting untreated psychiatric disorders among newly diagnosed breast cancer patients?

Cancer

Volumn 118, Issue 10, 2012, Pages 2735-2743

  Palmer, Steven C ^a   Taggi, Alison ^a   Demichele, Angela ^b   Coyne, James C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

adaptation; breast neoplasms psychology; depression; psychological; psychotropic drugs therapeutic use

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISTRESS SYNDROME; DRUG EFFECT; DYSTHYMIA; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MENTAL DISEASE; MENTAL HEALTH; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MENTAL DISORDERS; MIDDLE AGED; PSYCHOTROPIC DRUGS;

EID: 84860651209     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26603     Document Type: Article

References (72)

1. Patrick DL, Ferketich SL, Frame PS,. National Institutes of Health State-of-the-Science Conference Statement. Symptom management in cancer: pain, depression, and fatigue. July 15-17, 2002. J Natl Cancer Inst. 2004; 32: 9-16.
2. Adler NE, Page AEK, eds. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. Washington, DC: The National Academies Press; 2007
3. Holland JC, Bultz BD,. The NCCN guideline for distress management: a case for making distress the sixth vital sign. J Natl Compr Canc Netw. 2007; 5: 3-7.
4. Middleton H, Shaw I, Hull S, et al. NICE guidelines for the management of depression. BMJ. 2005; 330: 267-268.
5. United States Preventive Services Task Force,. Screening for depression: recommendations and rationale. Ann Intern Med. 2002; 136: 760-764.
6. Jacobsen PB, Ransom S,. Implementation of NCCN distress management guidelines by member institutions. J Natl Compr Canc Netw. 2007; 5: 99-103.
7. Coyne JC, Palmer SC, Shapiro PJ, et al. Distress, psychiatric morbidity and prescriptions for psychotropic medication in a breast cancer waiting room sample. Gen Hosp Psychiatry. 2004; 26: 121-128.
8. Mitchell AJ,. Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis. J Natl Compr Canc Netw. 2010; 8: 487-494.
9. Mitchell AJ,. Are one or two simple questions sufficient to detect depression in cancer and palliative care? A Bayesian meta-analysis. Br J Cancer. 2008; 98: 1934-1943.
10. Vodermaier A, Linden W, Siu C,. Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst. 2009; 101: 1464-1488.
11. Lloyd-Williams M, Friedman T, Rudd N,. An analysis of the validity of the Hospital Anxiety and Depression scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage. 2001; 22: 990-996.
12. Nelson CJ, Cho C, Berk AR, et al. Are gold standard depression measures appropriate for use in geriatric cancer patients? A systematic evaluation of self-report depression instruments used with geriatric, cancer, and geriatric cancer samples. J Clin Oncol. 2010; 28: 348-356.
13. Mitchell AJ,. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorder. J Clin Oncol. 2007; 25: 4670-4681.
14. Coyne JC, Thompson R, Palmer SC, et al. Should we screen for depression? Caveats and potential pitfalls. Appl Prev Psychol. 2000; 9: 101-121.
15. Palmer SC, Coyne JC,. Screening for depression in medical care: pitfalls, alternatives, and revised priorities. J Psychosom Res. 2003; 54: 279-287.
16. Thombs BD, Arthurs E, El-Baalbaki G, et al. Risk of bias from inclusion of patients who already have diagnosis of or are undergoing treatment for depression in diagnostic accuracy studies of screening tools for depression: systematic review. BMJ. 2011; 343: d4825.
17. Lloyd-Williams M, Friedman T, Rudd N,. Criterion validation of the Edinburgh Postnatal Depression Scale as a screening tool for depression in patients with advanced metastatic cancer. J Pain Symptom Manage. 2000; 20: 259-265.
18. Pyne JM, Rost KM, Farahati F, et al. One size fits some: the impact of patient treatment attitudes on the cost-effectiveness of a depression primary-care intervention. Psychol Med. 2005; 35: 839-854.
19. Fernandez A, Haro JM, Martinez-Alonso M, et al. Treatment adequacy for anxiety and depressive disorders in six European countries. Br J Psychiatry. 2007; 190: 172-173.
20. Mojtabai R, Olfson M,. National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the National Comorbidity Survey replication. J Clin Psychiatry. 2008; 69: 1064-1074.
21. Hinnen C, Ranchor AV, Sanderman R, et al. Course of distress in breast cancer patients, their partners, and matched control couples. Ann Behav Med. 2008; 36: 141-148.
22. Henselmans I, Helgeson VS, Seltman H, et al. Identification and prediction of distress trajectories in the first year after a breast cancer diagnosis. Health Psych. 2010; 29: 160-168.
23. Henselmans I, Sanderman R, Baas, et al. Personal control after a breast cancer diagnosis: stability and adaptive value. Psychooncology. 2009; 18: 104-108.
24. Lam WWT, Bonanno GA, Mancini AD, et al. Trajectories of psychological distress among Chinese women diagnosed with breast cancer. Psychooncology. 2010; 19: 1044-1051.
25. Millar K, Purushotham AD, McLatchie E, et al. A 1-year prospective study of individual variation in distress, and illness perceptions, after treatment for breast cancer. J Psychosom Res. 2005: 58: 335-342.
26. Stanton A, Danoff-Burg S, Huggins M,. The first year after breast cancer diagnosis: hope and coping strategies as predictors of adjustment. Psychooncology. 2002: 11: 93-102.
27. Hartl K, Engel J, Herschbach P, et al. Personality traits and psychosocial stress: quality of life over 2 years following breast cancer diagnosis and psychological impact factors. Psychooncology. 2010; 19: 160-169.
28. Hough RL, Landsverk JA, Stone JD, et al. Comparison of psychiatric screening questionnaires for primary care patients. Final report for NIMH Contract 278-0036 (DB). Bethesda, MD: National Institute of Mental Health; 1982.
29. Derogatis LR, Cleary PA,. Factorial invariance across gender for the primary symptom dimensions of the SCL-90. Br J Soc Clin Psychol. 1977; 16: 347-356.
30. Hesbacher P, Rickels K, Downing RW, et al. Assessment of psychiatric-illness severity by family physicians. Soc Sci Med. 1978; 12: 45-47.
31. Strong V, Waters R, Hibberd C, et al. Management of depression for people with cancer (SMaRT oncology 1): a randomized trial. Lancet. 2008; 372: 40-48.
32. Kroenke K, Theobald D, Wu J, et al. Effect of telecare management on pain and depression in patients with cancer: a randomized trial. JAMA. 2010; 304: 163-171.
33. van Scheppingen C, Schroevers, MJ, Smink, A, et al. Does screening for distress efficiently uncover meetable unmet needs in cancer patients? Psychooncology. 2011; 20: 655-663.
34. Kroenke K, Theobald D, Wu J, et al. Effect of telecare management on pain and depression in patients with cancer: a randomized trial. JAMA. 2010; 304: 163-171.
35. Schilder CM, Seynaeve C, Beex LV, et al. Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. J Clin Oncol. 2010; 28: 1294-1300.
36. Salzer MS, Palmer SC, Kaplan K, et al. A randomized, controlled study of Internet peer-to-peer interactions among women newly diagnosed with breast cancer. Psychooncology. 2010; 19: 441-446.
37. Radloff LS,. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977; 1: 385-401.
38. Cohen NJ, Coyne JC, Duvall J,. Adopted and biological children in the clinic: family, parental, and child characteristics. J Child Psychol Psychiat. 1993; 34: 542-562.
39. Cranford JA, Coyne JC, Sonnega J, et al. Psychological distress among male and female congestive heart failure patients and their spouses. Psychosom Med. 1998; 60: 105.
40. Hesbacher PT, Rickels K, Morris RJ, et al. Psychiatric illness in family practice. J Clin Psychiat. 1980; 41: 6-10.
41. First MB, Spitzer RL, Gibbon M, et al. Structured clinical interview for DSM-IV-TR Axis I disorders, research version, non-patient edition. New York: Biometrics Research, New York State Psychiatric Institute; 2001.
42. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington, DC: American Psychiatric Association; 1994.
43. Baer L, Brown-Beasley MW, Sorce J, et al. Computer-assisted telephone administration of a structured interview for obsessive compulsive disorder. Am J Psychiatry. 1993; 150: 1737-1738.
44. Kendler KS, Neale MC, Kessler RC, et al. A population based twin study of major depression in women: the impact of varying definitions of illness. Arch Gen Psychiatry. 1992; 49: 257-266.
45. Rhode P, Lewinsohn PM, Seeley JR,. Comparability of telephone and face-to-face interviews in assessing axis I and II disorders. Am J Psychiatry. 1997; 154: 1593-1598.
46. Wells KB, Burnam MA, Leake B, et al. Agreement between face-to-face and telephone administered versions of the depression section of NIMH Diagnostic Interview Schedule. J Psychiatr Res. 1988; 22: 207-220.
47. Agresti A, Coull BA,. Approximate is better than "exact" for interval estimation of binomial proportions. Am Stat. 1998; 52: 119-126.
48. Zabora J, BrintzenhofeSzoc K, Curbow B, et al. The prevalence of psychological distress by cancer site. Psychooncology. 2001; 10: 19-28.
49. Trask PC,. Assessment of depression in cancer patients. J Natl Cancer Inst Monogr. 2004; 32: 80-92.
50. Sharpe M, Strong V, Allen K, et al. Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs. Br J Cancer. 2004; 90: 314-320.
51. Walker J, Postma K, McHugh GS, et al. Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients. J Psychosom Res. 2007; 63: 83-91.
52. Evans DL, Charney DS, Lewis L, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry. 2005; 58: 175-189.
53. Olfson M, Marcus SC, Druss B, et al. National trends in the outpatient treatment of depression. JAMA. 2002; 287: 203-209.
54. Kessler RC, Demler O, Frank RG, et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med. 2005; 352: 2515-2523.
55. Olfson M, Marcus SC,. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009; 66: 848-856.
56. Ashbury FD, Madlensky L, Raich P, et al. Antidepressant prescribing in community cancer care. Support Care Cancer. 2003; 11: 278-285.
57. Klabunde CN, Ambs A, Keating NL, et al. The role of primary care physicians in cancer care. J Gen Intern Med. 2009; 24: 1029-1036.
58. Breitbart W, Rosenfeld B, Pessin H, et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA. 2000; 284: 2907-2911.
59. Benazon NR, Mamdani MM, Coyne JC,. Trends in the prescribing of antidepressants following acute myocardial infarction, 1993-2002. Psychosom Med. 2005; 67: 916-920.
60. DeRubeis RJ, Hollon SD, Dimidjian S,. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010; 303: 47-53.
61. Ackermann RT, Williams JW Jr,. National treatment choices for non-major depressions in primary care: an evidence-based review. J Gen Intern Med. 2002; 17: 293-301.
62. Lowe B, Unutzer J, Callahan CM, et al. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care. 2004; 42: 1194-1201.
63. Lowe B, Kroenke K, Grafe K,. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005; 58: 163-171.
64. Simon GE, VonKorff M, Rutter C, Wagner E,. Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ. 2000; 320: 550-554.
65. Patten SB,. A framework for describing the impact of antidepressant medications on population health status. Pharmacoepidemiol Drug Saf. 2002; 11: 549-559.
66. Sharpe M, Strong V, Allen K, et al. Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs. Br J Cancer. 2004; 90: 314-320.
67. Young AS, Klap R, Sherbourne CD, et al. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry. 2001; 58: 55-61.
68. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003; 289: 3095-3105.
69. Baas KD, Wittkampf KA, van Weert HC, et al. Screening for depression in high-risk groups: prospective cohort study in general practice. Br J Psychiatry. 2009; 194: 399-403.
70. Nutting PA, Rost K, Dickinson M, et al. Barriers to initiating depression treatment in primary care practice. J Gen Intern Med. 2002; 17: 103-111.
71. Chambless DL, Ollendick TH,. Empirically supported psychological interventions: controversies and evidence. Annu Rev Psychol. 2001; 52: 685-716.
72. Kessler R,. The difficulty of making psychology research and clinical practice relevant to medicine: experiences and observations. J Clin Psychol Med Settings. 2008; 15: 65-72.